Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing nilotinib (medicinal product) | Is a | Product containing protein-tyrosine kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing nilotinib (medicinal product) | Has active ingredient | Nilotinib (substance) | true | Inferred relationship | Some | 1 | |
| Product containing nilotinib (medicinal product) | Is a | Product containing enzyme inhibitor (product) | false | Inferred relationship | Some | ||
| Product containing nilotinib (medicinal product) | Is a | Nitrogen and/or nitrogen compound-containing product | false | Inferred relationship | Some | ||
| Product containing nilotinib (medicinal product) | Is a | Product containing imidazole (product) | true | Inferred relationship | Some | ||
| Product containing nilotinib (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing nilotinib (medicinal product) | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Is a | False | Product containing nilotinib (medicinal product) | Inferred relationship | Some | |
| Nilotinib-containing product in oral dose form | Is a | True | Product containing nilotinib (medicinal product) | Inferred relationship | Some | |
| Nilotinib only product | Is a | True | Product containing nilotinib (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets